- Home
- IMVT vs FORM Comparison
IMVT vs FORM Comparison
Compare IMVT & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- FORM
- Stock Information
- Founded
- IMVT 2018
- FORM 1993
- Country
- IMVT United States
- FORM United States
- Employees
- IMVT N/A
- FORM N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- FORM Semiconductors
- Sector
- IMVT Health Care
- FORM Technology
- Exchange
- IMVT Nasdaq
- FORM Nasdaq
- Market Cap
- IMVT 2.7B
- FORM 3.0B
- IPO Year
- IMVT N/A
- FORM N/A
- Fundamental
- Price
- IMVT $24.26
- FORM $54.63
- Analyst Decision
- IMVT Buy
- FORM Buy
- Analyst Count
- IMVT 9
- FORM 9
- Target Price
- IMVT $27.71
- FORM $51.88
- AVG Volume (30 Days)
- IMVT 1.5M
- FORM 1.0M
- Earning Date
- IMVT 11-10-2025
- FORM 10-29-2025
- Dividend Yield
- IMVT N/A
- FORM N/A
- EPS Growth
- IMVT N/A
- FORM N/A
- EPS
- IMVT N/A
- FORM 0.53
- Revenue
- IMVT N/A
- FORM $759,313,000.00
- Revenue This Year
- IMVT N/A
- FORM $3.95
- Revenue Next Year
- IMVT N/A
- FORM $10.24
- P/E Ratio
- IMVT N/A
- FORM $104.08
- Revenue Growth
- IMVT N/A
- FORM 2.29
- 52 Week Low
- IMVT $12.72
- FORM $22.58
- 52 Week High
- IMVT $29.49
- FORM $61.10
- Technical
- Relative Strength Index (RSI)
- IMVT 63.13
- FORM 62.53
- Support Level
- IMVT $21.86
- FORM $47.33
- Resistance Level
- IMVT $24.07
- FORM $54.92
- Average True Range (ATR)
- IMVT 1.25
- FORM 2.33
- MACD
- IMVT -0.18
- FORM -0.15
- Stochastic Oscillator
- IMVT 83.68
- FORM 90.45
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.